These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9083110)

  • 1. Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery.
    Salemme FR; Spurlino J; Bone R
    Structure; 1997 Mar; 5(3):319-24. PubMed ID: 9083110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.
    Nicolotti O; Giangreco I; Miscioscia TF; Convertino M; Leonetti F; Pisani L; Carotti A
    J Comput Aided Mol Des; 2010 Feb; 24(2):117-29. PubMed ID: 20148287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based design of macrocyclic factor XIa inhibitors: Discovery of cyclic P1 linker moieties with improved oral bioavailability.
    Clark CG; Rossi KA; Corte JR; Fang T; Smallheer JM; De Lucca I; Nirschl DS; Orwat MJ; Pinto DJP; Hu Z; Wang Y; Yang W; Jeon Y; Ewing WR; Myers JE; Sheriff S; Lou Z; Bozarth JM; Wu Y; Rendina A; Harper T; Zheng J; Xin B; Xiang Q; Luettgen JM; Seiffert DA; Wexler RR; Lam PYS
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126604. PubMed ID: 31445854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity study of serine proteases inhibitors.
    Perekhodtsev GD
    Mol Divers; 2006 Feb; 10(1):81-3. PubMed ID: 16404529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial tuning of peptidic drug candidates: high-affinity matriptase inhibitors through incremental structure-guided optimization.
    Fittler H; Avrutina O; Glotzbach B; Empting M; Kolmar H
    Org Biomol Chem; 2013 Mar; 11(11):1848-57. PubMed ID: 23361403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and structure-activity relationships of substituted piperazinone-based transition state factor Xa inhibitors.
    Su T; Yang H; Volkots D; Woolfrey J; Dam S; Wong P; Sinha U; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(4):729-32. PubMed ID: 12639568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based and combinatorial search for new RNA-binding drugs.
    Afshar M; Prescott CD; Varani G
    Curr Opin Biotechnol; 1999 Feb; 10(1):59-63. PubMed ID: 10047503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability.
    Andersson V; Bergström F; Brånalt J; Grönberg G; Gustafsson D; Karlsson S; Polla M; Bergman J; Kihlberg J
    J Med Chem; 2016 Jul; 59(14):6658-70. PubMed ID: 27347787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounds binding to the S2-S3 pockets of thrombin.
    Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
    J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A; Ehrhardt C; Metternich R; Tapparelli C
    Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRO_SELECT: combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology.
    Murray CW; Clark DE; Auton TR; Firth MA; Li J; Sykes RA; Waszkowycz B; Westhead DR; Young SC
    J Comput Aided Mol Des; 1997 Mar; 11(2):193-207. PubMed ID: 9089436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
    Karle M; Knecht W; Xue Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa.
    Böhm M; St rzebecher J; Klebe G
    J Med Chem; 1999 Feb; 42(3):458-77. PubMed ID: 9986717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a novel shape-based computational filter for lead evolution: application to thrombin inhibitors.
    Srinivasan J; Castellino A; Bradley EK; Eksterowicz JE; Grootenhuis PD; Putta S; Stanton RV
    J Med Chem; 2002 Jun; 45(12):2494-500. PubMed ID: 12036357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
    Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG
    J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in serine protease inhibitors as anticoagulant agents.
    Prezelj A; Anderluh PS; Peternel L; Urleb U
    Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions.
    Balakin KV; Savchuk NP; Tetko IV
    Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.